Warning Letter — Koven Technologies, Inc.
The FDA issued a Warning Letter to Koven Technologies, Inc. on July 21, 2026, following an inspection by the Center for Devices and Radiological Health (CDRH).
This affects Koven Technologies, Inc. and its internal departments responsible for quality management, regulatory compliance, and manufacturing oversight.
While the source does not detail specific violations, a Warning Letter from CDRH typically indicates significant deviations from Quality System Regulations (QSR). This suggests that the firm's existing quality controls may have been insufficient to meet federal standards, potentially requiring substantial remediation of manufacturing or documentation processes to avoid further enforcement action.
Quality and regulatory teams should perform a retrospective review of current production and post-market processes to ensure they align with Quality System Regulation requirements. Emphasis should be placed on documenting corrective actions and verifying that all quality management system (QMS) protocols are fully implemented.
FDA Warning Letter issued to: Koven Technologies, Inc.. 07/21/2026 — Center for Devices and Radiological Health. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/koven-technologies-inc-734643-07212026
Open in openFDA / FDA.gov